Myonex is the only clinical trial supply company that offers local, on-demand, direct-to-patient services for trials in North America and Europe as part of a comprehensive suite of solutions. From faster study start-up and lower costs, to better patient retention and reduced waste, the company’s innovative CTRx™ Pharmacy Solutions offer significant benefits to all parties involved in a clinical trial.
Services under our Clinical Trial Patient Solutions are currently available in the United States, Canada, and Europe and can be combined with other Myonex solutions as part of a global sourcing & distribution strategy.
Ready to talk further? Contact your Myonex representative or email [email protected] to discuss using Clinical Trial Patient Solutions for your next trial.
no waste leads to significant cost savings
no planning, forecasting or inventory management
fast study start up, site and patient centric (can be direct to patient)
access to specialty drug products (LDD and REMS)
“The Myonex Clinical Trial Prescription Service has been a game-changer for us. It has eliminated so many of the supply challenges of incorporating limited-distribution drugs in our trials, as Myonex’s pharmacy network dispenses and ships the drugs directly to our sites.”Clinical Trial Supply Manager
“We originally factored in 20% overage into our trial costs. Thanks to Myonex’s Clinical Trial Patient Solutions, specifically the CTRx Service, that was reduced to 0%, saving us $8 million for our oncology trial.”Clinical Trial Manager
“Due to Covid-19, we were unable to source our therapy after it was placed on allocation restriction. With Myonex’s CTRx Service from their Clinical Trial Patient Solutions, our patients were able to go to their local pharmacies to get their prescriptions filled – which allowed the trial to continue.”Clinical Trial Manager